These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19492148

  • 1. Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
    Zirlik A, Ernst S, Leugers A, Willecke F, Sobel BE, Bode C, Nordt TK.
    Thromb Haemost; 2009 Jun; 101(6):1060-9. PubMed ID: 19492148
    [Abstract] [Full Text] [Related]

  • 2. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
    Nordt TK, Lutzi S, Ruef J, Peter K, Klar E, Kübler W, Sobel BE, Bode C.
    Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X, Kanjanabuch T, Mao SL, Hao CM, Tang YW, Declerck PJ, Hasty AH, Wasserman DH, Fogo AB, Ma LJ.
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [Abstract] [Full Text] [Related]

  • 4. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
    Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, Tanne D, Matas Z, Hibuse T, Fujita K, Nishizawa H, Adler Y, Motro M, Kihara S, Shimomura I, Behar S, Funahashi T.
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889
    [Abstract] [Full Text] [Related]

  • 5. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
    Toyoda T, Kamei Y, Kato H, Sugita S, Takeya M, Suganami T, Ogawa Y.
    Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
    [Abstract] [Full Text] [Related]

  • 6. Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner.
    Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S.
    Mol Pharmacol; 2010 Jul; 78(1):135-41. PubMed ID: 20400680
    [Abstract] [Full Text] [Related]

  • 7. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 8. Modulation of adipose tissue development by pharmacological inhibition of PAI-1.
    Crandall DL, Quinet EM, El Ayachi S, Hreha AL, Leik CE, Savio DA, Juhan-Vague I, Alessi MC.
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2209-15. PubMed ID: 16825598
    [Abstract] [Full Text] [Related]

  • 9. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
    Kockx M, Princen HM, Kooistra T.
    Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
    [Abstract] [Full Text] [Related]

  • 10. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
    Berthou L, Duverger N, Emmanuel F, Langouët S, Auwerx J, Guillouzo A, Fruchart JC, Rubin E, Denèfle P, Staels B, Branellec D.
    J Clin Invest; 1996 Jun 01; 97(11):2408-16. PubMed ID: 8647932
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M, Roehle R, Maurer G, Huber K, Wojta J.
    Circulation; 2005 Apr 19; 111(15):1938-45. PubMed ID: 15837947
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of tumor necrosis factor-alpha-mediated plasminogen activator inhibitor-1 expression in adipocytes.
    Pandey M, Loskutoff DJ, Samad F.
    FASEB J; 2005 Aug 19; 19(10):1317-9. PubMed ID: 15928193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
    Duez H, Lefebvre B, Poulain P, Torra IP, Percevault F, Luc G, Peters JM, Gonzalez FJ, Gineste R, Helleboid S, Dzavik V, Fruchart JC, Fiévet C, Lefebvre P, Staels B.
    Arterioscler Thromb Vasc Biol; 2005 Mar 19; 25(3):585-91. PubMed ID: 15618549
    [Abstract] [Full Text] [Related]

  • 18. PPARα deficiency augments a ketogenic diet-induced circadian PAI-1 expression possibly through PPARγ activation in the liver.
    Oishi K, Uchida D, Ohkura N, Horie S.
    Biochem Biophys Res Commun; 2010 Oct 15; 401(2):313-8. PubMed ID: 20854792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes.
    Seki T, Miyasu T, Noguchi T, Hamasaki A, Sasaki R, Ozawa Y, Okukita K, Declerck PJ, Ariga T.
    J Cell Physiol; 2001 Oct 15; 189(1):72-8. PubMed ID: 11573206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.